Ambrosia no longer offers its controversial blood transfusions.
Ambrosia Health, the controversial clinic that sold transfusions of young, healthy people's blood, has "ceased patient treatments," according to the company's website.
The decision to stop taking patients comes after an official statement from FDA commissioner Scott Gottlieb this week, which described the company's practices as a dangerous scam.
Ambrosia claimed its transfusions of a younger person's blood could reverse health problems and extend a person's life — a controversial and unproven notion.
The company never published the results of its self-funded clinical experiments, and recent evidence suggests that these transfusions could have been dangerous from the start.
It's unclear whether Ambrosia plans to resume operations in the future or if the FDA's warning rang the company's death toll. Futurism reached out to the company with questions, and this article will be updated if we hear back.
Either way, the wealthy will need to get their controversial medical treatments somewhere else for the time being.
READ MORE: 'Young blood' company Ambrosia halts patient treatments after FDA warning [NBC]
More on Ambrosia Health: The FDA Warns: Transfusions of Young Blood Are a Dangerous Scam